• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR ABSOLUTE PRO .035 SELF EXPANDING STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR ABSOLUTE PRO .035 SELF EXPANDING STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM Back to Search Results
Catalog Number 1011921-100
Device Problems Difficult to Flush (1251); Premature Activation (1484); Difficult to Remove (1528); Stretched (1601); Improper or Incorrect Procedure or Method (2017); Difficult to Advance (2920); Migration (4003)
Patient Problem Foreign Body In Patient (2687)
Event Date 06/06/2023
Event Type  Injury  
Event Description
It was reported that the procedure was to treat a mildly calcified superficial femoral artery.The 6.0x100mm absolute pro self-expanding stent system (sess) was advanced and the stent was deployed.During removal of the sess, the stent caught on the shaft and the stent was stretched over 12 cm with the shaft.A second stent was needed to treat the target lesion.There was no adverse patient sequela and no clinically significant delay in the procedure.No additional information was provided.
 
Manufacturer Narrative
Manufacturer's investigation is still pending at this time.Results and conclusions will be provided in the final report.
 
Event Description
Subsequently, after the initial was filed it was reported that the stent was pulled back 12 cm remaining in the inferior portion of the femoral canal, but not stretched.Furthermore, during preparation of the stent it was noted there was difficulty felt when flushing the guide wire lumen and it was difficult to advance the stent over the wire.The sess was pulled back to flushed again; however, force was placed on the shaft, which moved the shaft and stent (premature deployment) before reinserting the stent.No additional information was provided.
 
Manufacturer Narrative
The device was returned for analysis.The reported difficult to flush, the reported difficult to advance-guide wire and the reported difficult to remove-guide wire were unable to be confirmed.The reported premature activation was unable to be replicated in a testing environment due to the condition of the returned device.The reported migration-stent and the reported difficult to remove-stent unable to be replicated in a testing environment as they were based on operational circumstances.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other incidents from this lot.It is possible that inadvertent mishandling during unpacking and/or preparation for use resulted in the noted wrinkled sheath; thus resulting in the reported difficult to flush, the reported difficult to advance and the reported difficult to remove over the guide wire.The noted wrinkled sheath and/or manipulation of the device possibly compromised the device resulting in the reported premature activation; however this cannot be confirmed.The investigation determined a conclusive cause for the reported difficult to flush, difficult to advance-guide wire, difficult to remove-guide wire and the reported premature activation difficulties cannot be determined.Additionally, the investigation determined the reported difficult to remove and the reported stent migration appear to be related to circumstances of the procedure as during removal, it is likely that the tip/shaft of the device inadvertently got caught on the deployed stent resulting in the reported difficult to remove and ultimately resulted in the reported stent migration.The treatment appears to be related to the operational context of the procedure as a second stent was needed to treat the target lesion.Reportedly, during preparation of the stent it was noted there was difficulty felt when flushing the guide wire lumen and it was difficult to advance the stent over the wire.It should be noted the absolute pro ll peripheral self-expanding stent system instructions for use (ifu) states: do not use if the package is open or damaged, or if the product is damaged.Additionally, warnings section 5.0 states: should unusual resistance be felt at any time during lesion or stricture access or delivery system removal, the introducer sheath / guiding catheter and stent system should be removed as a single unit.Applying excessive force to the stent delivery system can potentially result in loss or damage to the stent and delivery system components.It is undetermined if the deviation of the ifu caused/contributed to the reported difficulties.There is no indication of a product quality issue with respect to manufacture, design or labeling.H6: medical device problem code 1601 removed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ABSOLUTE PRO .035 SELF EXPANDING STENT SYSTEM
Type of Device
SELF EXPANDING PERIPHERAL STENT SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 2024168
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key17262108
MDR Text Key318441713
Report Number2024168-2023-07078
Device Sequence Number1
Product Code FGE
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
K072708
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 08/18/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number1011921-100
Device Lot Number2121361
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/14/2023
Initial Date FDA Received07/05/2023
Supplement Dates Manufacturer Received08/16/2023
Supplement Dates FDA Received08/18/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured12/13/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient SexMale
-
-